Certican 0.25mg Tablet

Certican 0.25mg Tablet contains the active ingredient Everolimus and is prescribed for various medical conditions, primarily as an immunosuppressant medication to prevent organ rejection after transplantation. Everolimus belongs to a class of drugs called mammalian target of rapamycin (mTOR) inhibitors, which work by suppressing the immune system and inhibiting the growth of certain cells in the body.

Uses:

Certican 0.25mg Tablet is used in combination with other immunosuppressive medications to prevent rejection of transplanted organs such as the kidney, liver, or heart. It may also be prescribed for the treatment of certain types of cancer, including advanced kidney cancer, breast cancer, and neuroendocrine tumors.

Administration:

Certican 0.25mg Tablet is taken orally, typically once daily or as directed by a healthcare professional. The dosage may vary depending on the patient’s medical condition, response to treatment, and other medications they may be taking. It is essential to follow the prescribed dosage regimen and not to adjust the dose without consulting a healthcare provider.

Side Effects:

Common side effects associated with Certican 0.25mg Tablet may include nausea, diarrhea, vomiting, mouth sores, loss of appetite, headache, dizziness, and fatigue. Some individuals may experience more severe side effects such as increased risk of infections, high blood sugar levels, high cholesterol levels, and changes in blood cell counts. It is important to report any unusual or bothersome symptoms to a healthcare provider.

Precautions:

Before starting Certican 0.25mg Tablet, patients should inform their healthcare provider of any medical conditions they have, especially if they have a history of infections, diabetes, or liver or kidney problems. Everolimus may increase the risk of infections and may affect blood sugar and cholesterol levels, so regular monitoring is essential during treatment. Patients should also avoid exposure to sunlight and use sunscreen to prevent skin reactions.

When Not to Use:

Certican 0.25mg Tablet should not be used in individuals who are allergic to Everolimus or any of its components. It is contraindicated in patients with active infections or with severe liver or kidney impairment. Everolimus may interact with certain medications, so patients should inform their healthcare provider of all the medications they are taking before starting treatment.